Company news
Taiko Pharmaceutical Co., Ltd. news in 2026
Taiko Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Notice of Approval of Transfer to the Standard Market and Withdrawal of the Plan to Comply with the Prime Market Continued Listing Criteria
October 26, 2026
Notice Concerning Application for a Market Division Change to the Tokyo Stock Exchange Standard Market
August 25, 2026
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (FY2026)
August 16, 2026
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (Under Japanese GAAP)
August 13, 2026
TABLE-Taiko Pharmaceutical -2025 group results
February 13, 2026